A Recurrent Loss-of-Function Alanyl-tRNA Synthetase (AARS) Mutation in Patients with Charcot-Marie-Tooth Disease Type 2N (CMT2N)
Main Authors: | Mclaughlin, H, Sakaguchi, R, Giblin, W, Wilson, T, Biesecker, L, Lupski, JR, Talbot, K, Vance, J, Züchner, S, Lee, Y, Kennerson, M, Hou, Y, Nicholson, G, Antonellis, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley-Liss Inc.
2014
|
Similar Items
-
A Recurrent Loss-of-Function Alanyl-tRNA Synthetase (AARS) Mutation in Patients with Charcot-Marie-Tooth Disease Type 2N (CMT2N)
by: Mclaughlin, H, et al.
Published: (2014) -
A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).
by: McLaughlin, H, et al.
Published: (2012) -
A Recurrent Loss-of-Function Alanyl-tRNA Synthetase (AARS) Mutation in Patients with Charcot-Marie-Tooth Disease Type 2N (CMT2N)
by: McLaughlin, H, et al.
Published: (2012) -
Impaired protein translation in Drosophila models for Charcot–Marie–Tooth neuropathy caused by mutant tRNA synthetases
by: Niehues, Sven, et al.
Published: (2015) -
A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo.
by: Vester, A, et al.
Published: (2013)